Literature DB >> 1943423

Treatment of oromandibular dystonia with botulinum toxin.

N Hermanowicz1, D D Truong.   

Abstract

Botulinum toxin produces muscle weakness by inhibition of acetylcholine release at the neuromuscular junction. The toxin has been used successfully for symptomatic treatment of focal dystonias. Our experience in the use of botulinum toxin for the treatment of oromandibular dystonia in five patients is reported. Improvement following treatment was reported as marked by 1 patient, moderate by 1 patient, and mild by 3 patients. Similar improvement was noted by the examiners. One patient with mild cosmetic improvement developed significant dysphagia requiring feeding by a nasogastric tube for a 3-month period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943423     DOI: 10.1288/00005537-199111000-00010

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Botulinum toxin for treatment of masseteric hypertrophy.

Authors:  Andrew Che Fai Hui
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

Review 2.  An update on the neurologic applications of botulinum toxins.

Authors:  Virgilio Gerald H Evidente; Charles H Adler
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

3.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

Review 4.  BOTOX: Broadening the Horizon of Dentistry.

Authors:  Pranav Nayyar; Pravin Kumar; Pallavi Vashisht Nayyar; Anshdeep Singh
Journal:  J Clin Diagn Res       Date:  2014-12-05

Review 5.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

6.  Treatment of focal dystonia.

Authors:  Amit Batla; Maria Stamelou; Kailash P Bhatia
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

7.  Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.

Authors:  Spiridon Papapetropoulos; Carlos Singer
Journal:  Head Face Med       Date:  2006-12-07       Impact factor: 2.151

8.  Oromandibular Dystonia: A Clinical Examination of 2,020 Cases.

Authors:  Laura M Scorr; Stewart A Factor; Sahyli Perez Parra; Rachel Kaye; Randal C Paniello; Scott A Norris; Joel S Perlmutter; Tobias Bäumer; Tatiana Usnich; Brian D Berman; Marie Mailly; Emmanuel Roze; Marie Vidailhet; Joseph Jankovic; Mark S LeDoux; Richard Barbano; Florence C F Chang; Victor S C Fung; Sarah Pirio Richardson; Andrew Blitzer; H A Jinnah
Journal:  Front Neurol       Date:  2021-09-16       Impact factor: 4.003

Review 9.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

Review 10.  Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia.

Authors:  Roongroj Bhidayasiri; Suppata Maytharakcheep; Daniel D Truong
Journal:  Clin Park Relat Disord       Date:  2022-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.